Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.

Prostate 2013 Jul 6;73(10):1057-68. Epub 2013 Feb 6.

Endocrinology Division, Department of Medicine, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, Quebec, Canada.

Background: Evidence shows that angiotensin II type 1 receptor (AT1R) blockers may be associated with improved outcome in prostate cancer patients. It has been proposed that part of this effect could be due to angiotensin II type 2 receptor (AT2R) activation, the only active angiotensin II receptor in this situation. This study aimed to characterize the localization and expression of AT2R in prostate tissues and to assess its role on cell morphology and number in prostatic epithelial cells in primary culture.

Methods: AT2R and its AT2R-interacting protein (ATIP) expression were assessed on non-tumoral and tumoral human prostate using tissue microarray immunohistochemistry, binding assay, and Western blotting. AT2R effect on cell number was measured in primary cultures of epithelial cells from non-tumoral human prostate.

Results: AT2R was localized at the level of the acinar epithelial layer and its expression decreased in cancers with a Gleason score 6 or higher. In contrast, ATIP expression increased with cancer progression. Treatment of primary cell cultures from non-tumoral prostate tissues with C21/M024, a selective AT2R agonist, alone or in co-incubation with losartan, an AT1R antagonist, significantly decreased cell number compared to untreated cells.

Conclusions: AT2R and ATIP are present in non-tumoral human prostate tissues and differentially regulated according to Gleason score. The decrease in non-tumoral prostate cell number upon selective AT2R stimulation suggests that AT2R may have a protective role against prostate cancer development. Treatment with a selective AT2R agonist could represent a new approach for prostate cancer prevention or for patients on active surveillance.

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.22653DOI Listing
July 2013
17 Reads
5 Citations
3.565 Impact Factor

Publication Analysis

Top Keywords

prostate cancer
16
human prostate
12
selective at2r
12
prostate tissues
12
cell number
12
prostate
10
at2r
10
non-tumoral human
8
angiotensin type
8
at2r agonist
8
non-tumoral prostate
8
gleason score
8
epithelial cells
8
type receptor
8
prostate tissue
8
atip expression
8
cancer
5
non-tumoral
5
cell
5
expression
5

References

(Supplied by CrossRef)
Angiotensin receptors: A new role in cancer
Deshayes et al.
Trends Endocrinol Metab 2005
The past, present and future of angiotensin II type 2 receptor stimulation
Steckelings et al.
J Renin Angiotensin Aldosterone Syst 2010
Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: A possibility of tyrosine kinase inhibitor of growth factor
Uemura et al.
Mol Cancer Ther 2003
Inflammation and angiotensin II
Suzuki et al.
Int J Biochem Cell Biol 2003

Similar Publications